公司資料
Eloxx 股價、新聞與催化劑
- 股票代碼:
- ELOX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
19.99 USD (-4.70%)
收盤價
最後更新: 2026年8月24日
—
市值
股價為何變動
As of Aug 24, 2026, ELOX closed down 4.70% at $19.99. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Eloxx Pharmaceuticals was a biotechnology company focused on rare disease and nonsense-mutation biology. Its story was built around precision approaches to difficult inherited disorders.
所在地與產業分類
Eloxx was headquartered in the United States and listed on NASDAQ. It sat in rare-disease biotechnology.
商業模式特徵
The business depended on translational progress, clinical validation, and the ability to keep a narrow pipeline funded. Investors generally watched early data and strategic changes.
生技產業定位
Eloxx occupies the historical rare-disease biotech bucket. Its value proposition was always tied to limited assets and the market's patience for development risk.
未來催化劑
- Eloxx’s catalysts are its nonsense-mutation and rare-disease pipeline, plus any update that clarifies whether the company can still keep the translational story alive. The next step matters because the company still needs clinical proof.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。